Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of Agrippal S1 2008-2009 influenza vaccine in non-elderly and elderly adults
2008-001079-31Phase 2Completed
- Sponsor
- Novartis
- Start
- May 2009
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of influenza vaccine, inactivated, surface antigen in influenza, sponsored by Novartis. Started May 2009; status: completed.
02
Drugs
influenza vaccine, inactivated, surface antigen
03
Conditions
influenza
Beyond the preview
Go deeper on 2008-001079-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001079-31.